Polycystic ovary syndrome (PCOS) affects 8–13% of women of reproductive age, making it the most common endocrine disorder in women. PCOS is characterised by hyperandrogenism (excess androgens), ovulatory dysfunction, and polycystic ovarian morphology. Insulin resistance drives the condition in 70–80% of cases by stimulating excess androgen production. Several supplements have meaningful RCT evidence for improving insulin sensitivity, reducing androgens, restoring ovulation, and improving fertility outcomes in PCOS — with some showing efficacy comparable to pharmaceutical interventions.
Best Supplements for Pcos
We assessed each supplement for clinical evidence quality, mechanism of action, dosing transparency, and safety. Evidence grades: A = strong RCT evidence; B = good clinical evidence; C = preliminary or emerging evidence.
Inositol is an insulin second messenger essential for normal ovarian function. Women with PCOS have impaired inositol signalling, contributing to insulin resistance and androgen excess. Multiple large RCTs show myo-inositol (2,000–4,000 mg/day) significantly restores ovulation, reduces androgens, improves insulin sensitivity, and in fertility-seeking women improves egg quality. The 40:1 myo:D-chiro inositol ratio is considered optimal for most women.
Activates AMPK, improving insulin sensitivity by the same mechanism as metformin. Multiple RCTs in PCOS show berberine significantly reduces fasting insulin, testosterone, LH:FSH ratio, and body weight. A head-to-head RCT found berberine comparable to metformin for improving metabolic and hormonal parameters in PCOS, with better GI tolerance in some studies.
Magnesium deficiency is significantly more common in insulin-resistant women and those with PCOS. Magnesium improves insulin receptor sensitivity, reduces inflammatory markers, and helps regulate the HPA axis (relevant for PCOS-associated cortisol dysregulation). Multiple studies show lower magnesium levels in PCOS patients correlate with worse metabolic and hormonal parameters.
Vitamin D receptors are expressed in ovarian tissue and regulate steroidogenesis. Vitamin D deficiency is extremely prevalent in PCOS (67–85% of patients). Multiple RCTs show D3 supplementation improves insulin resistance, reduces testosterone, improves menstrual regularity, and supports fertility outcomes in PCOS. One of the most consistently beneficial interventions in PCOS research.
EPA and DHA reduce systemic inflammation (elevated in PCOS), lower triglycerides (commonly elevated in insulin-resistant PCOS), improve insulin sensitivity, and reduce free androgen levels. A meta-analysis of RCTs found omega-3 supplementation significantly reduces testosterone levels in PCOS patients. Also supports mood and reduces the depression risk that is 3–6× elevated in PCOS.
NAC raises glutathione (the body's primary antioxidant), reduces insulin resistance, and has shown specific benefits in PCOS RCTs. A meta-analysis found NAC significantly improves ovulation rate, pregnancy rate, and metabolic parameters vs placebo. Head-to-head studies comparing NAC to metformin show similar efficacy for some parameters. Also addresses the elevated oxidative stress characteristic of PCOS.
⚠ Safety & Medical Disclaimer
PCOS is a complex endocrine disorder requiring medical diagnosis and monitoring. Supplements addressing insulin resistance (berberine, inositol) may significantly lower blood glucose — monitor if also using metformin. Do not use berberine during pregnancy. Inositol is considered safe in pregnancy and is used for gestational diabetes prevention. All supplement use should be disclosed to the treating gynaecologist or endocrinologist.
Frequently Asked Questions
Clinical References
All supplement recommendations are supported by peer-reviewed research. Key citations:
- Unfer V et al. (2017). Int J Endocrinol. Inositols in polycystic ovary syndrome: an overview. → Source
- Li Y et al. (2018). Phytomedicine. Therapeutic effect of berberine on metabolic diseases: both clinical and animal data. → Source
- Thomson RL et al. (2012). Clin Endocrinol (Oxf). Vitamin D deficiency is common and associated with metabolic risk factors in patients with PCOS. → Source
- Salehpour S et al. (2019). Sci Rep. N-Acetyl cysteine versus metformin for PCOS: a meta-analysis. → Source